Composition
- Active ingredients
- ETHOSUXIMIDE 250MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ETHOSUXIMIDE 250MG · CapsuleANDA210654-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleANDA200892-001 · Discontinued
- ETHOSUXIMIDE 250MG/5ML · SyrupANDA040506-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleANDA040430-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleThis page
- ETHOSUXIMIDE 250MG/5ML · SyrupANDA081306-001 · Discontinued
- ETHOSUXIMIDE 250MG · CapsuleANDA040686-001 · Prescription
- ETHOSUXIMIDE 250MG/5ML · SyrupANDA040253-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA211928.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ethosuximide
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Onesource Specialty
- Status
- Prescription
- FDA approval
- 19 Feb 2019
- Application
- ANDA211928-001